U.S. markets closed
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • Dow 30

    35,294.76
    +382.20 (+1.09%)
     
  • Nasdaq

    14,897.34
    +73.91 (+0.50%)
     
  • Russell 2000

    2,265.65
    -8.52 (-0.37%)
     
  • Crude Oil

    82.66
    +1.35 (+1.66%)
     
  • Gold

    1,768.10
    -29.80 (-1.66%)
     
  • Silver

    23.35
    -0.13 (-0.54%)
     
  • EUR/USD

    1.1606
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • GBP/USD

    1.3751
    +0.0074 (+0.54%)
     
  • USD/JPY

    114.2000
    +0.5230 (+0.46%)
     
  • BTC-USD

    61,504.27
    +2,300.58 (+3.89%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     
  • Nikkei 225

    29,068.63
    +517.70 (+1.81%)
     

eMagin Corporation Announces Third Quarter 2020 Results

  • Oops!
    Something went wrong.
    Please try again later.
·13 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Strong Military Sales Help Compensate for Lower Commercial Sales and Delayed Contract Revenues

  • Continuing to Supply the ENVG-B Night Vision and F-35 Helmet Mounted Display Programs

HOPEWELL JUNCTION, NY / ACCESSWIRE / November 12, 2020 / eMagin Corporation, or the "Company", (NYSE American:EMAN), a leader in the development, design and manufacture of Active Matrix OLED microdisplays used in Military and Commercial AR/VR devices, and other near-eye imaging products, today announced results for the third quarter 2020.

"The Company is reporting that third-quarter revenues were $7.3 million as compared to revenue of $7.9 million a year ago. Military display sales increased as eMagin supplied sole-sourced products to support the ENVG-B program as it ramps to volume, as well as other key military programs worldwide. However, we were impacted by the economic disruption of COVID-19 in certain non-military applications as customers delayed purchases for elective surgery systems as well as high-end sportsman's rifle scopes. We increased R&D investment in dPd™ technology which in the near term should drive more contract revenue, and next quarter we expect to start receiving equipment under our $39.1 million Department of Defense ("DoD") awards for OLED technology, which we announced in June and July," commented CEO Andrew G. Sculley.

"We experienced continued strength in our military display business, which at $5.5 million for the quarter, increased 19% year-over-year. Our U.S. military business was strong in the quarter as we accelerated our support of the ENVG-B program for close combat soldiers, and produced displays for the F-35 head mounted display helmet program. We are the sole supplier for the multi-year ENVG-B program, and have supported the build-out of initial units delivered to the U.S. Army. We will continue to supply the program through its low rate initial production phase in 2021 and beyond. In international markets, we recorded increased shipments across Asian, Middle Eastern and European markets and supplied an initial order to one of the top five European military electronics manufacturers, a new relationship for eMagin."

"Non-military display revenue declined, attributed to the economic disruption of the COVID-19 pandemic. Specifically, sales for elective eye surgery equipment and sportsman's rifle scope were lower compared to the same quarter last year. We have already begun to see recovery in the eye care market and recently booked over $1 million in orders for delivery beginning in April 2021. Our third-quarter contract revenue declined $0.3 million due to timing of various projects."

"We continue to see strong interest in our high brightness direct patterned ("dPdTM") technology and believe it to be the best solution for AR/VR. We are making steady progress on the development efforts of our dPd technology and our high brightness product roadmap, and have demonstrated an increase in throughput on our new dPd tool by a factor of three. Our total R&D work has brought us close to achieving our brightness milestone of 10,000cd/m2 for a full-color display using a single stack architecture. These improvements will be combined with new tooling on the next version of dPd. Future roadmap milestones will make use of tandem, or double structures and other improvements that we believe will allow us to stay ahead of the competition in providing the highest brightness displays to the marketplace," continued Mr. Sculley.

"We are excited about the completion of wafer design for one of our Tier One consumer customers at the end of the second quarter. The foundry is now working on the fabrication of the wafers, which will be returned to us for dPd processing. We expect our contract revenue to increase in the fourth quarter as we continue to work on these innovative technologies."

"From an operating perspective, our quarterly operating loss increased by $1.5 million to $1.9 million from the prior year mainly related to the decrease in non-military revenues and the increased investments in our R&D efforts for our dPd and XLE processes to maintain our technological edge and our innovative product mix."

"During the quarter, we placed orders for the new equipment provided for under the first phase of our DoD awards and are in the design/order phase for additional equipment to be provided under this $39.1 million program. The machinery included in these programs will be used to enhance manufacturing reliability, increase yield and throughput, and provide a production tool for our high brightness dPd process. In December, the first new piece of equipment to arrive will be an advanced testing and diagnostic tool for use in our clean room. We expect that this new machine will help us enhance yield and anticipate seeing the improvement beginning in the first quarter of 2021. Additional early phase equipment is due to arrive in the second quarter of 2021 and will undergo testing and qualification."

"At the end of the quarter, we had $10.3 million in cash and cash equivalents, and borrowings outstanding and borrowings available under our ABL facility of $0.5 million and $2.3 million, respectively. Included in this amount is $1.96 million from a PPP loan, which the Company has used to maintain full employment and which we expect to be forgiven. Our backlog remains strong at $10.0 million of which $9.4 million is shippable within the next twelve months."

"Our product lines of market-leading, domestically produced microdisplays have been designed into a broad range of applications and have been recognized for their reliability, resolution and high brightness for over twenty years. We are pleased to be at the forefront of the military's effort to incorporate AR/VR into their advanced weapons systems and look forward to providing our customers the benefit of the increased manufacturing capability made possible by the government awards," concluded Mr. Sculley.

Third Quarter Results
Total revenues for the third quarter of 2020 were $7.3 million, a decrease of 0.6 million from revenues of $7.9 million reported in the prior-year period, and a decrease of $0.4 million from the second quarter of 2020.

Total revenue consists of both product revenue and contract revenue. Product revenues for the third quarter of 2020 were $7.0 million, a decrease of $0.3 million from product revenues of $7.3 million reported in the prior-year period. The decrease in display revenue for the quarter resulted from lower sales to commercial and medical customers due to the economic impact of COVID-19. Contract revenues were $0.3 million compared to $0.6 million reported in the prior year reflecting an increased contribution from military and consumer NRE work in the prior year.

Total gross margin for the third quarter was 23% on gross profit of $1.7 million compared to a gross margin of 31% on gross profit of $2.5 million in the prior-year period. The decrease in gross margins was impacted by the lower shipment of displays and revenues as compared to the comparable 2019 period.

Operating expenses for the third quarter of 2020, including R&D expenses, were $3.6 million as compared to $2.9 million reported in the prior-year period. Operating expenses as a percentage of sales were 49% in the third quarter of 2020 compared to 36% reported in the prior-year period. R&D expenses were higher in the third quarter, primarily reflecting increased investments in R&D projects related to dPd technology and our XLE display development.

Operating loss for the third quarter of 2020 was $1.9 million compared to an operating loss of $0.4 million in the prior-year period. Net loss for the third quarter of 2020 was $3.5 million or $0.06 per share compared to a loss of $0.3 million or $0.01 per share in the prior-year period. Net loss for the current and prior year periods reflects a $1.8 million non-cash loss and $0.1 million non-cash gain related to the change in fair value of a warrant liability, respectively. Excluding the impact of the change in the fair value of the warrant liability, net loss for the third quarter of 2020 was $0.03 per share versus a net loss of $0.01 per share in the year-ago quarter.

Adjusted EBITDA the third quarter was negative $1.1 million compared to a positive $0.3 million in the prior-year period.

At September 30, 2020, the Company had cash and cash equivalents of $10.3 million and working capital of $14.5 million. During the third quarter, the Company used the remaining amount available under an At the Market equity facility to raise $6.5 million. Borrowings and availability under the ABL facility were $0.5 million and $2.3 million respectively at September 30, 2020.

Conference Call Information
eMagin will hold a Webcast at 9:00 am (New York time) on November 12, 2020 to discuss its third-quarter results. To access the live webcast or archive, please visit the Company's website at ir.emagin.com or use the following link https://www.webcaster4.com/Webcast/Page/2471/37991. An archive of the webcast will be available one hour after the live call.

About eMagin Corporation
The leader in OLED microdisplay technology for the next generation of computing and imaging devices, serving world-class customers in the military and consumer, medical and industrial markets. We invent, engineer and manufacture display technologies of the future in the USA, including our Direct Patterning Technology (dPd) that will transform the way the world consumes information. Since 2001, our microdisplays have been, and continue to be, used in AR/VR, aircraft helmets, heads-up display systems, thermal scopes, night vision goggles, future weapon systems and a variety of other applications. www.emagin.com

Important Cautionary Information Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding eMagin Corporation's expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in the Company's most recent filings with the SEC. For a more complete description of the risks factors that could cause our actual results to differ from our current expectations, including impacts of the COVID-19 pandemic, please see the section entitled "Risk Factors" in eMagin's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and in any Form 10-Q filed or to be filed by eMagin, and in other documents we file with the SEC from time to time.

CONTACT
eMagin Corporation
Mark A. Koch
Acting Chief Financial Officer
845-838-7951
mkoch@emagin.com

Affinity Growth Advisors
Betsy Brod
212-661-2231
betsy.brod@affinitygrowth.com

eMAGIN CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)

September 30,

December 31,

2020

2019

ASSETS

Current assets:

Cash and cash equivalents

$

10,283

$

3,515

Restricted cash

1,800

-

Accounts receivable, net

3,178

3,966

Unbilled accounts receivable

31

155

Inventories

8,133

8,832

Prepaid expenses and other current assets

1,796

1,130

Total current assets

25,221

17,598

Equipment, furniture and leasehold improvements, net

8,147

8,100

Operating lease right - of - use assets

3,166

3,729

Intangibles and other assets

128

160

Total assets

$

36,662

$

29,587

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

1,009

$

1,302

Accrued compensation

1,700

1,778

Paycheck Protection Program loan - current

735

-

Revolving credit facility, net

490

2,891

Common stock warrant liability

3,327

23

Other accrued expenses

1,604

1,401

Deferred revenue

393

277

Operating lease liability - current

826

775

Other current liabilities

632

342

Total current liabilities

10,716

8,789

Other liability - long term

67

24

Paycheck Protection Program loan - long term

1,228

-

Deferred Income - Government awards - long term

2,263

-

Operating lease liability - long term

2,441

3,067

Total liabilities

16,715

11,880

Commitments and contingencies

Shareholders' equity:

Preferred stock, $.001 par value: authorized 10,000,000 shares:

Series B Convertible Preferred stock, (liquidation preference of $5,659) stated value $1,000 per share, $.001 par value: 10,000 shares designated and 5,659 issued and outstanding as of September 30, 2020 and December 31, 2019.

-

-

Common stock, $.001 par value: authorized 200,000,000 shares, issued 67,661,668 shares, outstanding 67,499,602 shares as of September 30, 2020 and issued 50,250,378 shares, outstanding 50,088,312 shares as of December 31, 2019.

68

50

Additional paid-in capital

268,720

258,767

Accumulated deficit

(248,341

)

(240,610

)

Treasury stock, 162,066 shares as of September 30, 2020 and December 31, 2019.

(500

)

(500

)

Total shareholders' equity

19,947

17,707

Total liabilities and shareholders' equity

$

36,662

$

29,587

eMAGIN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Revenues:

Product

$

6,978

$

7,321

$

18,872

$

17,786

Contract

333

598

2,870

1,606

Total revenues, net

7,311

7,919

21,742

19,392

Cost of revenues:

Product

5,385

5,112

15,153

14,436

Contract

234

316

1,487

904

Total cost of revenues

5,619

5,428

16,640

15,340

Gross profit

1,692

2,491

5,102

4,052

Operating expenses:

Research and development

1,734

1,046

4,313

3,943

Selling, general and administrative

1,824

1,839

5,334

5,555

Total operating expenses

3,558

2,885

9,647

9,498

Loss from operations

(1,866

)

(394

)

(4,545

)

(5,446

)

Other income (expense):

Change in fair value of common stock warrant liability

(1,803

)

120

(3,304

)

1,450

Interest expense, net

(10

)

(41

)

(45

)

(96

)

Other income, net

148

-

163

-

Total other (expense) income

(1,665

)

79

(3,186

)

1,354

Loss before provision for income taxes

(3,531

)

(315

)

(7,731

)

(4,092

)

Income taxes

-

-

-

-

Net loss

$

(3,531

)

$

(315

)

$

(7,731

)

$

(4,092

)

Loss per share, basic and diluted

$

(0.06

)

$

(0.01

)

$

(0.14

)

$

(0.09

)

Weighted average number of shares outstanding:

Basic and Diluted

57,736

49,174

54,451

47,719

Non-GAAP Financial Measures
To supplement the Company's consolidated financial statements presented on a GAAP basis; the Company has provided non-GAAP financial information, namely earnings before interest, taxes, depreciation and amortization, and non-cash compensation expense ("Adjusted EBITDA"). The Company's management believes that this non-GAAP measure provides investors with a better understanding of how the results relate to the Company's historical performance. The additional adjusted information is not meant to be considered in isolation or as a substitute for GAAP financial statements. Management believes that these adjusted measures reflect the essential operating activities of the Company. A reconciliation of non-GAAP financial information appears below (in thousands).

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Net loss

$

(3,531

)

$

(315

)

$

(7,731

)

$

(4,092

)

Non-cash compensation

60

165

147

455

Change in fair value of common stock warrant liability

1,803

(120

)

3,304

(1,450

)

Depreciation and intangibles amortization expense

522

493

1,481

1,480

Interest expense

10

41

45

96

Adjusted EBITDA

$

(1,136

)

$

264

$

(2,754

)

$

(3,511

)

SOURCE: eMagin Corporation



View source version on accesswire.com:
https://www.accesswire.com/616175/eMagin-Corporation-Announces-Third-Quarter-2020-Results